The protective effects afforded by this DPP-IV inhibitor may derive from improvement of metabolic profile (related to amelioration of glycaemic and lipidic levels and of insulin resistance) and from cytoprotective properties. This evidence concerns the gene DPP4 and Insulin resistance.